Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis
Abstract Background Propofol is a kind of common intravenous anaesthetic agent that plays an anti-tumor role in a variety of cancers, including ovarian cancer. However, the working mechanism of Propofol in ovarian cancer needs further exploration. Methods The viability and metastasis of ovarian canc...
Main Authors: | Huan Lu, Guanlin Zheng, Xiang Gao, Chanjuan Chen, Min Zhou, Longxin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13048-021-00775-3 |
Similar Items
-
Circular RNA-VPS13A attenuates diabetes-induced enteric glia damage by targeting miR-182/GDNF axis
by: Zhu Xiaowei, et al.
Published: (2022-07-01) -
Caspase 3‐specific cleavage of MEK1 suppresses ERK signaling and sensitizes cells to stress‐induced apoptosis
by: Hisashi Moriizumi, et al.
Published: (2023-04-01) -
Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145
by: Hongyang Sui, et al.
Published: (2019-03-01) -
Generation and characterization of MEK and ERK inhibitors- resistant non-small-cells-lung-cancer (NSCLC) cells
by: Alice Iezzi, et al.
Published: (2018-10-01) -
Cobimetinib and trametinib inhibit platelet MEK but do not cause platelet dysfunction
by: Amanda J. Unsworth, et al.
Published: (2019-08-01)